Literature DB >> 1251777

Thromboembolic complications, heparin treatment in increase in coagulation factors in Cushing's syndrome.

H E Sjöberg, M Blombäck, P O Granberg.   

Abstract

Seven of 19 consecutive patients with Cushing's syndrome demonstrated thromboembolic manifestations before or after adrenal ectomy. These were successfully treated with heparin. The mean values of coagulation factors VIII (AHF) and V as well as prothrombin were increased. There was a positive correlation between the increase in factor VIII content and the severity of disease. The possibility that these changes in blood coagulation activity reflect an increased coagulability state in Cushing's syndrome is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1251777     DOI: 10.1111/j.0954-6820.1976.tb06697.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  14 in total

1.  Venous thrombo-embolism following inferior petrosal sinus sampling in Cushing's disease.

Authors:  K Obuobie; J S Davies; A Ogunko; M F Scanlon
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

2.  Recurrent thromboembolism as a hallmark of Cushing's syndrome.

Authors:  A La Brocca; M Terzolo; A Pia; P Paccotti; P De Giuli; A Angeli
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

3.  A venous thromboembolism risk assessment model for patients with Cushing's syndrome.

Authors:  Marialuisa Zilio; Linda Mazzai; Maria Teresa Sartori; Mattia Barbot; Filippo Ceccato; Viviana Daidone; Alessandra Casonato; Graziella Saggiorato; Franco Noventa; Laura Trementino; Paolo Prandoni; Marco Boscaro; Giorgio Arnaldi; Carla Scaroni
Journal:  Endocrine       Date:  2015-06-26       Impact factor: 3.633

Review 4.  Epidemiology of venous thromboembolism.

Authors:  W W Coon
Journal:  Ann Surg       Date:  1977-08       Impact factor: 12.969

5.  Postoperative venous thromboembolism and brain tumors: Part I. Clinical profile.

Authors:  R Sawaya; M Zuccarello; M Elkalliny; H Nishiyama
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

6.  Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers.

Authors:  Darko Kastelan; Tina Dusek; Ivana Kraljevic; Ozren Polasek; Zlatko Giljevic; Mirsala Solak; Silva Zupancic Salek; Jozo Jelcic; Izet Aganovic; Mirko Korsic
Journal:  Endocrine       Date:  2009-04-21       Impact factor: 3.633

Review 7.  The coagulation system in endocrine disorders: a narrative review.

Authors:  A Squizzato; V E A Gerdes; W Ageno; H R Büller
Journal:  Intern Emerg Med       Date:  2007-07-09       Impact factor: 3.397

8.  Cushing's disease due to an unusually large adenoma of the pituitary gland in infancy.

Authors:  H Stegner; D K Lüdecke; M Kadrnka-Lovrenćić; N Stahnke; R P Willig
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

9.  Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels.

Authors:  C Erem; I Nuhoglu; M Yilmaz; M Kocak; A Demirel; O Ucuncu; H Onder Ersoz
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

Review 10.  Thromboembolic complications associated with brain tumors.

Authors:  R E Sawaya; B L Ligon
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.